Shanghai Haohai Biological Technology Co., Ltd.

SHSC:6826 Stock Report

Market Cap: HK$13.7b

Shanghai Haohai Biological Technology Management

Management criteria checks 4/4

Shanghai Haohai Biological Technology's CEO is Jianying Wu, appointed in Jul 2010, has a tenure of 14.42 years. directly owns 3.69% of the company’s shares, worth HK$506.54M. The average tenure of the management team and the board of directors is 10 years and 11.1 years respectively.

Key information

Jianying Wu

Chief executive officer

CN¥1.9m

Total compensation

CEO salary percentagen/a
CEO tenure14.4yrs
CEO ownership3.7%
Management average tenure10yrs
Board average tenure11.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jianying Wu's remuneration changed compared to Shanghai Haohai Biological Technology's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

CN¥430m

Jun 30 2024n/an/a

CN¥446m

Mar 31 2024n/an/a

CN¥432m

Dec 31 2023CN¥2mn/a

CN¥416m

Sep 30 2023n/an/a

CN¥346m

Jun 30 2023n/an/a

CN¥315m

Mar 31 2023n/an/a

CN¥226m

Dec 31 2022CN¥2mCN¥855k

CN¥180m

Sep 30 2022n/an/a

CN¥203m

Jun 30 2022n/an/a

CN¥192m

Mar 31 2022n/an/a

CN¥272m

Dec 31 2021CN¥1mCN¥845k

CN¥352m

Sep 30 2021n/an/a

CN¥428m

Jun 30 2021n/an/a

CN¥434m

Mar 31 2021n/an/a

CN¥370m

Dec 31 2020CN¥1mCN¥768k

CN¥230m

Sep 30 2020n/an/a

CN¥232m

Jun 30 2020n/an/a

CN¥216m

Mar 31 2020n/an/a

CN¥279m

Dec 31 2019CN¥2mCN¥742k

CN¥371m

Sep 30 2019n/an/a

CN¥353m

Jun 30 2019n/an/a

CN¥386m

Mar 31 2019n/an/a

CN¥375m

Dec 31 2018CN¥1mCN¥712k

CN¥415m

Sep 30 2018n/an/a

CN¥411m

Jun 30 2018n/an/a

CN¥408m

Mar 31 2018n/an/a

CN¥390m

Dec 31 2017CN¥1mCN¥583k

CN¥372m

Compensation vs Market: Jianying's total compensation ($USD260.98K) is below average for companies of similar size in the Hong Kong market ($USD511.75K).

Compensation vs Earnings: Jianying's compensation has been consistent with company performance over the past year.

CEO

Jianying Wu (60 yo)

14.4yrs

Tenure

CN¥1,904,800

Compensation

Dr. Jianying Wu has been General Manager of Shanghai Haohai Biological Technology Co., Ltd. since July 23, 2010 and has been its Executive Director since December 2014. Mr. Wu served as a Director at Shang...

Leadership Team

NamePositionTenureCompensationOwnership
Yongtai Hou
Executive Chairman14.4yrsCN¥1.89m3.65%
HK$ 501.4m
Jianying Wu
GM & Executive Director14.4yrsCN¥1.90m3.69%
HK$ 506.5m
Minjie Tang
CFO & Executive Director8yrsCN¥1.45m0.036%
HK$ 5.0m
Yiyi Chen
Executive Director10yrsCN¥1.26m0.26%
HK$ 35.4m
Min Tian
Joint Company Secretary5yrsCN¥868.70k0.0044%
HK$ 606.9k
Caixia Ren
Deputy General Manager10.3yrsCN¥912.50k0.012%
HK$ 1.6m
Ming King Chiu
Joint Company Secretary10.1yrsno datano data

10.0yrs

Average Tenure

49yo

Average Age

Experienced Management: 6826's management team is seasoned and experienced (10 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yongtai Hou
Executive Chairman14.4yrsCN¥1.89m3.65%
HK$ 501.4m
Jianying Wu
GM & Executive Director14.4yrsCN¥1.90m3.69%
HK$ 506.5m
Minjie Tang
CFO & Executive Director7.8yrsCN¥1.45m0.036%
HK$ 5.0m
Yiyi Chen
Executive Director14.4yrsCN¥1.26m0.26%
HK$ 35.4m
Hongbo Shen
Independent Non-Executive Directorless than a yearno datano data
Jie You
Non Executive Director14.4yrsno data46.4%
HK$ 6.4b
Ming Ping Huang
Non-Executive Director14.4yrsCN¥150.00k1.22%
HK$ 166.9m
Yuanzhong Liu
Chairman of the Supervisory Committee14.4yrsno data1.22%
HK$ 166.9m
Lei Zhao
Independent Non-Executive Director4.5yrsCN¥150.00kno data
Zhi Su
Independent Non-Executive Director4.5yrsCN¥150.00kno data
Zhihong Jiang
Independent Non-Executive Director4.5yrsCN¥150.00kno data
Yushe Yang
Independent Non-Executive Director4.5yrsCN¥150.00kno data

11.1yrs

Average Tenure

52.5yo

Average Age

Experienced Board: 6826's board of directors are seasoned and experienced ( 11.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 06:14
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Haohai Biological Technology Co., Ltd. is covered by 17 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jingwei QiChina Merchants Securities Co. Ltd.
Xiaofang XuCitic Securities Co., Ltd.
Eva ZhaoCitigroup Inc